Salik, B.* ; Yi, H.* ; Hassan, N.* ; Santiappillai, N.* ; Vick, B. ; Connerty, P.* ; Duly, A.* ; Trahair, T.* ; Woo, A.J.* ; Beck, D.* ; Liu, T.* ; Spiekermann, K.* ; Jeremias, I. ; Wang, J.* ; Kavallaris, M.* ; Haber, M.* ; Norris, M.D.* ; Liebermann, D.A.* ; D'Andrea, R.J.* ; Murriel, C.* ; Wang, J.Y.*
Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia.
Cancer Cell 38, 263-278.e6 (2020)
Signals driving aberrant self-renewal in the heterogeneous leukemia stem cell (LSC) pool determine aggressiveness of acute myeloid leukemia (AML). We report that a positive modulator of canonical WNT signaling pathway, RSPO-LGR4, upregulates key self-renewal genes and is essential for LSC self-renewal in a subset of AML. RSPO2/3 serve as stem cell growth factors to block differentiation and promote proliferation of primary AML patient blasts. RSPO receptor, LGR4, is epigenetically upregulated and works through cooperation with HOXA9, a poor prognostic predictor. Blocking the RSPO3-LGR4 interaction by clinical-grade antiRSPO3 antibody (OMP-131R10/rosmantuzumab) impairs self-renewal and induces differentiation in AML patient-derived xenografts but does not affect normal hematopoietic stem cells, providing a therapeutic opportunity for HOXA9-dependent leukemia.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Acute Myeloid Leukemia ; Aml ; Hoxa9 ; Leukemia Stem Cells ; Lgr4 ; Lsc ; Rspo ; Self-renewal ; Signaling Pathway ; Wnt/β-catenin; Beta-catenin; Hematopoietic Stem; Gene-expression; Self-renewal; Mll; Progenitor; Hoxa9; Cancer; Transformation; Maintenance
Keywords plus
Language
english
Publication Year
2020
Prepublished in Year
HGF-reported in Year
2020
ISSN (print) / ISBN
1535-6108
e-ISSN
1878-3686
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 38,
Issue: 2,
Pages: 263-278.e6
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge, Mass.
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
POF-Topic(s)
30204 - Cell Programming and Repair
Research field(s)
Stem Cell and Neuroscience
PSP Element(s)
G-506600-001
Grants
Copyright
Erfassungsdatum
2020-07-09